Senior Scientist II, Upstream Process Development and MSAT

Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.

As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.

 

The Technical Operations Organization at Scholar Rock is seeking a scientifically accomplished and motivated scientist in the Upstream Process Development and MSAT group. The successful candidate will be responsible for developing and optimizing cell culture processes for antibody production and be comfortable working on multiple priorities at once across both development and manufacturing. Significant experience with mammalian cell culture techniques (ideally CHO cells) and bioreactor operation is required. The selected candidate will work alongside both in-house and CDMO scientists to advance existing projects through the development and product lifecycle and help start up new projects.